Log in

ASX:PMEPro Medicus Stock Price, Forecast & News

A$26.98
+0.68 (+2.59 %)
(As of 05/13/2020)
Add
Compare
Today's Range
A$25.82
Now: A$26.98
A$27.12
50-Day Range
A$20.74
MA: A$25.17
A$27.28
52-Week Range
A$14.50
Now: A$26.98
A$38.39
Volume285,954 shs
Average VolumeN/A
Market Capitalization$2.80 billion
P/E Ratio127.87
Dividend Yield0.39%
BetaN/A
Pro Medicus Limited provides radiology information systems (RIS), picture archiving and communication systems (PACS), and advanced visualization solutions worldwide. It offers medical software for practice management; integration products; Promedicus.net secure email; healthcare software that provides radiologist and clinicians with advanced visualization capability for viewing 2-D, 3-D, and 4-D medical images; and PACS/Digital imaging software. The company offers its products under the Visage RIS, Visage RIS/PACS, and Visage 7 names. It also provides Visage Ease Pro, a mobile applications, which allow users access to medical imaging results that are stored on a Visage 7 server; training, installation, and professional services; and after sale support and service products. The company offers its products and services to hospitals, diagnostic imaging groups, and other health related entities. Pro Medicus Limited was founded in 1983 and is headquartered in Richmond, Australia.
Read More

Beat the Market (BTM) Rank

Analyst Opinion: 0.0Community Rank: 2.6Dividend Strength: 2.5Insider Behavior: 3.0Valuation: 0.0 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

1.62 out of 5 stars


Industry, Sector and Symbol

Industry Health Information Services
Sub-IndustryN/A
SectorComputer and Technology
CUSIPN/A
CIKN/A
Phone61 3 9429 8800

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$54.08 million
Cash FlowA$0.38 per share
Book ValueA$0.50 per share

Profitability

Miscellaneous

EmployeesN/A
Market Cap$2.80 billion
Next Earnings DateN/A
OptionableNot Optionable

Receive PME News and Ratings via Email

Sign-up to receive the latest news and ratings for PME and its competitors with MarketBeat's FREE daily newsletter.

Pro Medicus (ASX:PME) Frequently Asked Questions

How has Pro Medicus' stock been impacted by COVID-19 (Coronavirus)?

Pro Medicus' stock was trading at A$16.65 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization (WHO). Since then, PME shares have increased by 62.0% and is now trading at A$26.98. View which stocks have been most impacted by Coronavirus.

How often does Pro Medicus pay dividends? What is the dividend yield for Pro Medicus?

Pro Medicus announced a Interim dividend on Friday, February 14th. Shareholders of record on Friday, March 20th will be given a dividend of 0.06 per share on Friday, March 20th. This represents a dividend yield of 0.24%. The ex-dividend date is Thursday, March 5th. This is a boost from Pro Medicus's previous Interim dividend of A$0.04. View Pro Medicus' dividend history.

Has Pro Medicus been receiving favorable news coverage?

Press coverage about PME stock has trended extremely negative recently, InfoTrie Sentiment Analysis reports. The research firm ranks the sentiment of media coverage by analyzing more than six thousand blog and news sources. The firm ranks coverage of companies on a scale of negative five to positive five, with scores closest to five being the most favorable. Pro Medicus earned a media sentiment score of -4.8 on InfoTrie's scale. They also assigned media coverage about the company a news buzz of 0.0 out of 10, meaning that recent media coverage is extremely unlikely to have an effect on the stock's share price in the next several days. View the latest news aboutPro Medicus.

Who are some of Pro Medicus' key competitors?

What other stocks do shareholders of Pro Medicus own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Pro Medicus investors own include ImmuPharma (IMM), Blackmores (BKL), Bank of America (BAC), Boeing (BA), Accent Group (AX1), Axos Financial (AX), ARB (ARB), Appen (APX), Arista Networks (ANET) and Altium (ALU).

Who are Pro Medicus' key executives?

Pro Medicus' management team includes the following people:
  • Dr. Sam Aaron Hupert, Co-Founder, Deputy Chairman, CEO & MD
  • Mr. Anthony Barry Hall, Co-Founder, Technology Director & Exec. Director
  • Dr. Malte Westerhoff, Global Chief Technology Officer
  • Mr. Brad Levin, GM of North America & Global Head of Marketing
  • Mr. Danny Tauber, Gen. Mang. of Australia

What is Pro Medicus' stock symbol?

Pro Medicus trades on the ASX under the ticker symbol "PME."

What is Pro Medicus' stock price today?

One share of PME stock can currently be purchased for approximately A$26.98.

How big of a company is Pro Medicus?

Pro Medicus has a market capitalization of $2.80 billion and generates $54.08 million in revenue each year.

What is Pro Medicus' official website?

The official website for Pro Medicus is www.promed.com.au.

How can I contact Pro Medicus?

The company can be reached via phone at 61 3 9429 8800.

This page was last updated on 5/26/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.